Stocks · Health care · Pharmaceutical Preparations

Edesa Biotech, Inc.

EDSA Clue Score49
British Columbia, Canada Fiscal year ends September CIK 0001540159 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Lorin K Johnson
9 Nov 2020
Director
Exercised, kept
4,262
$4.00
$17.05K
Kathi Niffenegger
6 Nov 2020
Chief Financial Officer
Exercised, kept indirect
609
$4.00
$2.44K
Michael J Brooks
6 Nov 2020
President
Exercised, kept
914
$4.00
$3.66K
Paul William Pay
6 Nov 2020
Director
Exercised, kept
1,218
$4.00
$4.87K
Pardeep Nijhawan
5 Nov 2020
Chief Executive Officer
Exercised, kept indirect
4,628
$4.00
$18.51K
Carlo Sistilli
5 Nov 2020
Director
Exercised, kept indirect
1,218
$4.00
$4.87K
der Velden Peter van
2 Nov 2020
Director
Exercised, kept indirect
5,952
$4.00
$23.81K
der Velden Peter van
2 Nov 2020
Director
Exercised, kept indirect
64,362
$4.00
$257.45K
Frank R. Oakes
6 Oct 2020
Director
Exercised, kept indirect
609
$4.00
$2.44K

What was left out

Form 4 filings counted 209
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 7,779,768
Sales filed before the plan box existed 16
History held since 13 Nov 2014